Table 6.1.1: Stock and Flow, 1996-2007 Year199619971998199920002001200220032004200520062007 New transplant 4322217132022219345 Deaths* 104303323000 Lost.

Slides:



Advertisements
Similar presentations
Cemetery Demography Lab October Table 3: Data Calculations for Survivorship Curve Age Class Years # Deaths in Class (d) # Surviving from Birth (I)
Advertisements

CHAPTER 3 HEART AND LUNG TRANSPLANTATION Editors: Mr Mohamed Ezani Md. Taib Dato’ Dr David Chew Soon Ping Dr Ashari Yunus Expert Panel: Mr Mohamed Ezani.
P449. p450 Figure 15-1 p451 Figure 15-2 p453 Figure 15-2a p453.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
CHAPTER 2 CORNEAL TRANSPLANTATION
© ANZOD Registry International Donor Statistics 1997 % of Multiple Organ Donors Donors PMP % Mult. Donors Eurotransplant:Germany, Austria, Belgium, Luxembourg,
Australian States Number of Donors Per Million Population Aust * NSW population excludes residents of the NSW Southern Area.
Living Donor Kidneys in PAK 2/11 USA Primary DD Pancreas Transplants 1/1/1988 – 12/31/2010.
CHAPTER 12 Peritoneal Dialysis Sunita Bavanandan Lily Mushahar Anita Bhajan Manocha Source: 20 th MDTR Report 2012, NRR.
Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths
Table 5.1.1: Stock and Flow of Renal Transplantation, Year New transplant patients
Chapter 4: Quality of life and rehabilitation outcomes of patients on Dialysis Liu Wen Jiun Chew Thian Fook Christopher Lim Thiam Seong Tan Wee Ming Yia.
INFLUENCE OF HLA MISMATCH ON GRAFT SURVIVAL IN RENAL TRASPLANTATION IN ADULTS IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi.
CHAPTER 4 LIVER TRANSPLANTATION Editors: Dr Ganesalingam A/L Kanagasabai Expert panel: Dr Ganesalingam A/L Kanagasabai (Chairperson) Professor Dr Lee Way.
Table 2.1.1: Number of Cornea Transplantation and Transplant Rate per million population (pmp), Year No.
Table 5.1.1: Stock and Flow of Renal Transplantation, Year New transplant patients
Table 2.1.1: New Transplant Rate per million population (pmp), Year New transplants
Life expectancy of patients treated with ART in the UK: UK CHIC Study Margaret May University of Bristol, Department of Social Medicine, Bristol.
CHAPTER 5: PAEDIATRIC RENAL REPLACEMENT THERAPY Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Yap Yok Chin Wan Jazilah Wan Ismail Source: 21 st MDTR.
Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths
CHAPTER 2 DIALYSIS IN MALAYSIA Goh Bak Leong Lim Yam Ngo Ong Loke Meng Ghazali Ahmad Lee Day Guat Source: 21 st MDTR Report 2013, NRR.
CHAPTER 13 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato’ Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan.
CHAPTER 4 Paediatric Renal Biopsies Lee Ming Lee Lim Yam Ngo Lynster Liaw Mirunalini a/p Appadurai Selva Kumar a/l Sivapuniam Susan Pee Wan Jazilah Wan.
INTERMACS: June 2006 – December 2012: CMS Report Adults: n=7849 All primary implants as of 12/31/2012 n= 7928 Pediatric patients: n=79 (patients < 19 yrs.
CHAPTER 1: ALL RENAL REPLACEMENT THERAPY IN MALAYSIA Lim Yam Ngo Ong Loke Meng Goh Bak Leong Lee Day Guat Source: 20 th MDTR Report 2012, NRR.
CHAPTER 1 BLOOD AND MARROW TRANSPLANTATION Editors: Dr Alan Teh Kee Hean Prof Dr Chan Lee Lee Expert Panel: Dr Alan Teh Kee Hean (co-chairperson) Prof.
Table 5.1.1: Stock and Flow of Renal Transplantation, Year New transplant patients
Editors: Datin Dr Lela Yasmin Mansor Expert Panel Datin Dr Lela Yasmin Mansor (chairperson) Dr Hooi Lai Seong Dr Omar Sulaiman Dr Muhammed Anis Abdul Wahab.
Table 8.1: Number of Procurement by Year, Number of procurement by year Total=162 Year Number of donors
CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato’ Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan.
 Kidney  Pancreas  Liver  Heart 1954 by Murray/Harrison 1966 by Lillehei 1967 by Starzl 1968 by Barnard.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
CHAPTER 11 Haemodialysis Practices Tan Chwee Choon Shahnaz Shah Firdaus Khan Rafidah Abdullah Norleen Bt Zulkarnain Sim Source: 20 th MDTR Report 2012,
Table 8.1: Number of procurement by year, Number of procurement by year Total=137 Year Number of donors
Table 3.1.1: Stock and Flow of Heart Transplantation, Year New transplant patients Deaths
CHAPTER 6 HOMOGRAFT - HEART VALVE TRANSPLANTATION Editor: Mr Mohamed Ezani Md. Taib Expert Panel: Mr Mohamed Ezani Md. Taib (Chairperson) Dr Abdul Rais.
CHAPTER 13 Renal Transplantation Goh Bak Leong Fan Kin Sing Rohan Malek Bin Dato’ Dr. Johan Rosnawati Yahya S. Prasad Menon Tan Si Yen Wong Hin Seng Source:
Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation, Year New transplant patients Deaths
Chapter 1 ALL RENAL REPLACEMENT THERAPY IN MALAYSIA
Table 4.1.1: Stock and Flow of Liver Transplantation, Year * ** New transplant patients Deaths.
Table 3.1.1: Stock and Flow of Heart Transplantation, Year New transplant patients Deaths
1 “The Effects of Sociodemographic Factors on the Hazard of Dying Among Aged Chinese Males and Females” Dudley L. Poston, Jr. and Hosik Min Department.
Chapter 3 Death and Survival on Dialysis Wong Hin Seng Ong Loke Meng Source: 20 th MDTR Report 2012, NRR.
CHAPTER 2 DIALYSIS IN MALAYSIA Goh Bak Leong Lim Yam Ngo Ong Loke Meng Ghazali Ahmad Lee Day Guat Source: 20 th MDTR Report 2012, NRR.
Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation, Year New transplant patients Deaths
International DataU.S.FranceGermanyNetherlandsCanadaUK Pregnancy rate (2002-5) Birth rate (2006)
Table 2.1.1: Number of Corneal Transplantation and Transplant Rate per million population (pmp), Year
THE AUSTRALIA AND NEW ZEALAND CARDIOTHORACIC ORGAN TRANSPLANT REGISTRY
First-year death rates by modality figure 8
Table 3.1.1a: Stock and Flow of Heart Transplantation,
Mortality rates in incident ESRD patients figure 9
Number of transplants, by donor type figure 8.1
December 31st point prevalent counts by modality figure 3.1
HEART-LUNG TRANSPLANTATION
CHAPTER 5 Paediatric Renal Replacement Therapy
CHAPTER 11: Haemodialysis Practices
CHAPTER 1 All Renal Replacement Therapy In Malaysia
HEART-LUNG TRANSPLANTATION
THE AUSTRALIA AND NEW ZEALAND CARDIOTHORACIC ORGAN TRANSPLANT REGISTRY
Table 1.1.1: Stock and Flow of Blood and Marrow Transplantation,
HEART-LUNG TRANSPLANTATION
National Cancer Statistics in Korea, 2015
Table 6.1.1: Stock and Flow, *based on year of death Year
HEART-LUNG TRANSPLANTATION
Ruth H. Keogh, Sanja Stanojevic  Journal of Cystic Fibrosis 
CHAPTER 2 PRIMARY GLOMERULONEPHRITIS
Table 6.1.1: Stock and Flow, Year
Figure Prevalence of coronary artery disease by year or
HEART-LUNG TRANSPLANTATION
Presentation transcript:

Table 6.1.1: Stock and Flow, Year New transplant Deaths* Lost to follow up Alive with functioning graft at 31 st December *based on year of death Figure 6.1.1: Stock and Flow,

Table 6.2.1: Distribution of Patients by Gender, Year TOTAL GenderNo. Male Female TOTAL Figure 6.2.1: Distribution of Patients by Gender,

Table 6.2.2: Distribution of Patients by Ethnic Group, Year TOTAL Ethnic groupNo. Malay Chinese Indian Others TOTAL Figure 6.2.2: Distribution of Patients by Ethnic Group,

Table 6.2.3: Distribution of Patients by Age, Year TOTAL Age groupNo ≥ TOTAL Mean SD Median Min 53 months 125 months months Max * Age=date of implantation – date birth Figure 6.2.3: Distribution of Patients by Age, ≥60 years

Table 6.3.1: Number of Valves Harvested by Type of Homograft, Year TOTAL Type of homograft No. Aortic Pulmonary TOTAL Table 6.3.2: Type of Transplant, Year TOTAL Type of transplant No. Aortic Pulmonary TOTAL Figure 6.3.2: Type of Transplant,

Table 6.4.1: Patient Survival by Gender, GenderMaleFemale Interval (years)% SurvivalSE% SurvivalSE SE=standard error Figure 6.4.1: Patient Survival by Gender,

≥20 years Table 6.4.2: Patient Survival by Age Group, Age group0-9 years10-19 years≥20 years Interval (months)% SurvivalSE% SurvivalSE% SurvivalSE SE=standard error Figure 6.4.2: Patient Survival by Age Group,

Table 6.4.3: Patient Survival by Type of Homograft, Type of homograftAorticPulmonary Interval (years)% SurvivalSE% SurvivalSE SE=standard error Figure 6.4.3: Patient Survival by Type of Homograft,